Available Technologies

Browse Penn-owned technologies available for licensing.


Search Results - henry daniell

2 Results Sort By:
Protein drugs encapsulated in plant cells as low-cost prevention and treatment of lung injury in COVID-19 patients
Use of functional recombinant ACE2 and Angiotensin-(1-7) proteins to improve the clinical course of patients with symptomatic COVID-19 infection. Problem: COVID-19 is associated with high rates of respiratory failure, cardiac injury and death. Patients suffering from COVID-19 generally present with reduced expression of angiotensin converting enzyme...
Published: 6/2/2020   |   Inventor(s): Henry Daniell
Keywords(s): COVID-19
Category(s): Therapeutics & Vaccines
Oral Delivery of Human Therapeutic Proteins Bio-Encapsulated Within Plant Cells to Confer Protection Against Inherited Or Infectious Diseases
Technology Overview: Dr. Daniell has developed a new drug delivery platform that is a low cost alternative to current methods of human therapeutic protein delivery. The inventor has demonstrated that biopharmaceuticals fused with transmucosal carriers can be expressed in plant cells and then freeze-dried. This bio-encapsulated therapeutic can...
Published: 1/23/2020   |   Inventor(s): Henry Daniell
Category(s): Therapeutics & Vaccines